These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26101724)

  • 1. Topical Ocular Drug Delivery to the Back of the Eye by Mucus-Penetrating Particles.
    Schopf LR; Popov AM; Enlow EM; Bourassa JL; Ong WZ; Nowak P; Chen H
    Transl Vis Sci Technol; 2015 Jun; 4(3):11. PubMed ID: 26101724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular Pharmacokinetics of a Novel Loteprednol Etabonate 0.4% Ophthalmic Formulation.
    Schopf L; Enlow E; Popov A; Bourassa J; Chen H
    Ophthalmol Ther; 2014 Dec; 3(1-2):63-72. PubMed ID: 25134493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine A Nanosuspensions for Ophthalmic Delivery: A Comparative Study between Cationic Nanoparticles and Drug-Core Mucus Penetrating Nanoparticles.
    Yan R; Xu L; Wang Q; Wu Z; Zhang H; Gan L
    Mol Pharm; 2021 Dec; 18(12):4290-4298. PubMed ID: 34731571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of KPI-121 0.25% in the treatment of dry eye disease: penetrating the mucus barrier to treat periodic flares.
    Gupta PK; Venkateswaran N
    Ther Adv Ophthalmol; 2021; 13():25158414211012797. PubMed ID: 34017938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged exposure to loteprednol etabonate in human tear fluid and rabbit ocular tissues following topical ocular administration of Lotemax gel, 0.5%.
    Glogowski S; Lowe E; Siou-Mermet R; Ong T; Richardson M
    J Ocul Pharmacol Ther; 2014 Feb; 30(1):66-73. PubMed ID: 24325539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Eye Drop Formulation for Potential Treatment of Neovascular Age-Related Macular Degeneration.
    Huang WC; Cheng F; Chen CC; Kuo PH; Wang YJ; Yin SC; Tu CM; Wu MH; Wang WY; Chen SE
    Transl Vis Sci Technol; 2021 Dec; 10(14):23. PubMed ID: 34932116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical Delivery of Anti-VEGF Drugs to the Ocular Posterior Segment Using Cell-Penetrating Peptides.
    de Cogan F; Hill LJ; Lynch A; Morgan-Warren PJ; Lechner J; Berwick MR; Peacock AFA; Chen M; Scott RAH; Xu H; Logan A
    Invest Ophthalmol Vis Sci; 2017 May; 58(5):2578-2590. PubMed ID: 28494491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucus-Penetrating Particles and the Role of Ocular Mucus as a Barrier to Micro- and Nanosuspensions.
    Popov A
    J Ocul Pharmacol Ther; 2020; 36(6):366-375. PubMed ID: 32667250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of topical ocular nepafenac and its active metabolite amfenac to the posterior segment of the eye.
    Chastain JE; Sanders ME; Curtis MA; Chemuturi NV; Gadd ME; Kapin MA; Markwardt KL; Dahlin DC
    Exp Eye Res; 2016 Apr; 145():58-67. PubMed ID: 26474497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and posterior segment biodistribution of ESBA105, an anti-TNF-alpha single-chain antibody, upon topical administration to the rabbit eye.
    Furrer E; Berdugo M; Stella C; Behar-Cohen F; Gurny R; Feige U; Lichtlen P; Urech DM
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):771-8. PubMed ID: 18757508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical delivery of aqueous micellar resolvin E1 analog (RX-10045).
    Cholkar K; Gilger BC; Mitra AK
    Int J Pharm; 2016 Feb; 498(1-2):326-34. PubMed ID: 26706439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A preliminary evaluation of dexamethasone palmitate emulsion: a novel intravitreal sustained delivery of corticosteroid for treatment of macular edema.
    Daull P; Paterson CA; Kuppermann BD; Garrigue JS
    J Ocul Pharmacol Ther; 2013 Mar; 29(2):258-69. PubMed ID: 23331052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Emerging Role of Topical Ocular Drugs to Target the Posterior Eye.
    Wang L; Zhou MB; Zhang H
    Ophthalmol Ther; 2021 Sep; 10(3):465-494. PubMed ID: 34218424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of circulation on the disposition and ocular tissue distribution of 20 nm nanoparticles after periocular administration.
    Amrite AC; Edelhauser HF; Singh SR; Kompella UB
    Mol Vis; 2008 Jan; 14():150-60. PubMed ID: 18334929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical, Aqueous, Clear Cyclosporine Formulation Design for Anterior and Posterior Ocular Delivery.
    Cholkar K; Gilger BC; Mitra AK
    Transl Vis Sci Technol; 2015 May; 4(3):1. PubMed ID: 25964868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innovations in topical ocular corticosteroid therapy for the management of postoperative ocular inflammation and pain.
    Salinger CL; Gaynes BI; Rajpal RK
    Am J Manag Care; 2019 Jul; 25(12 Suppl):S215-S226. PubMed ID: 31419092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of topical hesperetin matrix film for back-of-the-eye delivery.
    Adelli GR; Hingorani T; Punyamurthula N; Balguri SP; Majumdar S
    Eur J Pharm Biopharm; 2015 May; 92():74-82. PubMed ID: 25728824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Long-Lasting Potential of Suprachoroidal Axitinib Suspension Via Ocular and Systemic Disposition in Rabbits.
    Kansara VS; Muya LW; Ciulla TA
    Transl Vis Sci Technol; 2021 Jun; 10(7):19. PubMed ID: 34128964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transscleral Coulomb-controlled iontophoresis of methylprednisolone into the rabbit eye: influence of duration of treatment, current intensity and drug concentration on ocular tissue and fluid levels.
    Behar-Cohen FF; El Aouni A; Gautier S; David G; Davis J; Chapon P; Parel JM
    Exp Eye Res; 2002 Jan; 74(1):51-9. PubMed ID: 11878818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular tissue distribution and pharmacokinetic study of a small 13kDa domain antibody after intravitreal, subconjuctival and eye drop administration in rabbits.
    Gough G; Szapacs M; Shah T; Clements P; Struble C; Wilson R
    Exp Eye Res; 2018 Feb; 167():14-17. PubMed ID: 29074387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.